These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1417380)

  • 41. Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study.
    Cosci F; Bertoli G; Abrams K
    Depress Anxiety; 2013 Dec; 30(12):1217-21. PubMed ID: 23554155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The transdermal nicotine patch: results of a randomised placebo-controlled trial.
    Richmond RL; Harris K; de Almeida Neto A
    Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression.
    Thorsteinsson HS; Gillin JC; Patten CA; Golshan S; Sutton LD; Drummond S; Clark CP; Kelsoe J; Rapaport M
    Neuropsychopharmacology; 2001 Apr; 24(4):350-8. PubMed ID: 11182530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized trial of nortriptyline for smoking cessation.
    Prochazka AV; Weaver MJ; Keller RT; Fryer GE; Licari PA; Lofaso D
    Arch Intern Med; 1998 Oct; 158(18):2035-9. PubMed ID: 9778204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: a double-blind study in healthy smokers.
    Khoury Z; Comans P; Keren A; Lerer T; Gavish A; Tzivoni D
    Cardiovasc Drugs Ther; 1996 May; 10(2):179-84. PubMed ID: 8842510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain.
    Jorenby DE; Hatsukami DK; Smith SS; Fiore MC; Allen S; Jensen J; Baker TB
    Psychopharmacology (Berl); 1996 Nov; 128(2):130-8. PubMed ID: 8956374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transdermal nicotine for active ulcerative colitis.
    Pullan RD; Rhodes J; Ganesh S; Mani V; Morris JS; Williams GT; Newcombe RG; Russell MA; Feyerabend C; Thomas GA
    N Engl J Med; 1994 Mar; 330(12):811-5. PubMed ID: 8114833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.
    JAMA; 1991 Dec; 266(22):3133-8. PubMed ID: 1956099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combining clonidine and nicotine replacement for treatment of nicotine withdrawal.
    Sees KL; Stalcup SA
    J Psychoactive Drugs; 1989; 21(3):355-9. PubMed ID: 2681633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms.
    Fagerström KO; Schneider NG; Lunell E
    Psychopharmacology (Berl); 1993; 111(3):271-7. PubMed ID: 7870963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial.
    Robinson MD; Pettice YL; Smith WA; Cederstrom EA; Sutherland DE; Davis H
    J Am Board Fam Pract; 1992; 5(1):1-9. PubMed ID: 1561909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial.
    Schneider NG; Olmstead R; Mody FV; Doan K; Franzon M; Jarvik ME; Steinberg C
    Addiction; 1995 Dec; 90(12):1671-82. PubMed ID: 8555958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial.
    Baumgartner GR; Rowen RC
    South Med J; 1991 Mar; 84(3):312-21. PubMed ID: 2000517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
    Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
    Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial.
    Glassman AH; Stetner F; Walsh BT; Raizman PS; Fleiss JL; Cooper TB; Covey LS
    JAMA; 1988 May; 259(19):2863-6. PubMed ID: 3367452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting.
    Franks P; Harp J; Bell B
    JAMA; 1989 Dec; 262(21):3011-3. PubMed ID: 2681856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical evaluation of the contact sensitization potential of a transdermal nicotine system (Nicoderm).
    Jordan WP
    J Fam Pract; 1992 Jun; 34(6):709-12. PubMed ID: 1593244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A test of proposed new tobacco withdrawal symptoms.
    Etter JF; Ussher M; Hughes JR
    Addiction; 2013 Jan; 108(1):50-9. PubMed ID: 22702228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized clinical trial of atenolol in patients with alcohol withdrawal.
    Kraus ML; Gottlieb LD; Horwitz RI; Anscher M
    N Engl J Med; 1985 Oct; 313(15):905-9. PubMed ID: 2863754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A controlled comparison of clonidine and doxepin in the treatment of the opiate withdrawal syndrome.
    Täschner KL
    Pharmacopsychiatry; 1986 May; 19(3):91-5. PubMed ID: 3523550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.